(5-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid, 98%, 25g

2-(1-Methylpiperidin-4-yl)ethanamine, 95.0%, 5g

2-Chloro-N-(2,4-dichloro-benzyl)-acetamide, 100mg

1-(2,2,2-TRIFLUOROACETAMIDO)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 250g

2-Methyl-2,3-dihydrophthalazine-1,4-dione, 98%, 1g

2-(Pyridin-4-yl)-1H-benzo[d]imidazole-6-carboxylic acid, 95.0%, 5g

7-Chloro-4-methoxy-2,3-dihydro-1h-indole-2,3-dione, 97%, 250mg

4-Bromophenyl trifluoromethanesulfonate, 98%, 5g

2-Methylterephthalic acid, 95.0%, 10g

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)

METHYL 2-OXO-2,3-DIHYDRO-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXYLATE, 95.0%, 250mg

Methyl 3-Amino-4-methylbenzoate, 97.0%, 25g

3-Bromo-4-methoxyaniline>96.0%(GC)(T)1g